Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 …7thSpace Interactive (press release)RA patients on rituximab had significantly lower (P <0.001) and SpA on anti-TNF monotherapy significantly better response rates compared to …
|
Research and Markets: Pricing patterns for Monoclonal Antibodies (mAbs) are …
Financial Mirror There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix. The current market leader is Avastin, which generated revenues … |
|
Research and Markets: Pricing patterns for Monoclonal Antibodies (mAbs) are …
Business Wire (press release) There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix. The current market leader is Avastin, which generated revenues … |
Insights On Genetic Origins of Disease, Treatment StrategiesScience Daily (press release)Turning the focus to the understanding of drugs, one study identifies the specific cellular mechanism of the commonly used drug lenalidomide and a second concludes…
|
NICE favours Cell Therapeutics’ Pixuvri/Bayer’s Eylea
PharmaTimes In final draft guidance, the Appraisal Committee concluded that Pixuvri is indeed cost-effective, but only for patients who have previously been treated with MabThera (rituximab) and those receiving third or fourth line treatment. In these scenarios … |
|
Higher mortality in postmenopausal women with RA and anti-CCP antibodies
Science Daily (press release) Dec. 23, 2013 — New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Findings published in the American College of Rheumatology … |
Pharmacists, Students Improve Organ Donation RatesPharmacy Practice NewsDesensitization typically involves plasmapheresis and/or a combination of medications, such as IV immunoglobulin and rituximab, to reduce the amount and strength of circulating ant…
Choosing the Right In Vitro Test for Your MonoclonalGenetic Engineering NewsConsider Rituximab, a mAb approved for the treatment of lymphoma and rheumatoid arthritis. Rituximab works by recognizing a specific protein, CD20, that sits on the surface of …
Arthritis Patients: Get Your Flu ShotsArthritis TodayA recent literature review that examined 12 studies on the subject found that methotrexate decreases the response to the pneumonia vaccine and possibly the flu vaccine, and rituximab decreases the re…
Psoriatic arthritis patients showed greater levels of progranulin antibodiesHealioPatients with psoriatic arthritis, particularly those with dactylitis or enthesitis, displayed significant levels of neutralizing progranulin antibodies that were not pre…